Obesity
- Top Stories
Novo Nordisk sues Hims & Hers over compounded obesity drugs
Novo Nordisk is taking legal action against online telehealth provider Hims & Hers for marketing cheaper, unapproved versions of the…
Read More » - Health
Hims & Hers won’t sell compounded version of Novo’s obesity pill
Hims & Hers announced on Saturday that it would discontinue the sale of a compounded version of Novo Nordisk’s obesity…
Read More » - Health
Employers drop obesity drug coverage as cash-pay programs grow
HCA Healthcare, one of the largest hospital systems in the U.S., recently made a decision that has caught the attention…
Read More » - Health
WHO issues guidance on GLP-1 drugs for obesity, calls them a “scientific breakthrough” and “new chapter”
The World Health Organization (WHO) has released new guidelines recommending the use of GLP-1 drugs for the treatment of obesity.…
Read More » - Health
World Health Organization Recommends GLP-1 Drugs Like Ozempic For Obesity. Here’s What To Know
The World Health Organization has recently issued global guidance on the use of GLP-1 drugs for the treatment of obesity,…
Read More » - Health
Trump’s Price Cuts For Obesity Drugs Raise More Questions Than Answers
President Trump made headlines today with the announcement of agreements with pharmaceutical giants Novo Nordisk and Eli Lilly to lower…
Read More » - Health
Obesity rate is declining as more Americans use weight loss drugs, survey finds
A recent survey conducted by Gallup has revealed a promising trend in the fight against obesity in the United States.…
Read More » - Money
Novo Nordisk says it’s cutting 9,000 workers amid increased competition for its obesity drug Wegovy
Novo Nordisk, a Danish pharmaceutical company known for its weight-loss drug Wegovy, announced on Wednesday that it will be cutting…
Read More » - Health
Novo Nordisk’s obesity drug Wegovy cleared to treat live disease MASH
Novo Nordisk’s obesity drug Wegovy has received approval from U.S. regulators to treat metabolic dysfunction-associated steatohepatitis (MASH), a common liver…
Read More » - Money
Trump won’t force Medicaid to cover GLP-1s for obesity. A few states are doing it anyway.
Obesity is a prevalent health issue that affects millions of individuals across the country. For many, traditional methods of weight…
Read More »